Arising in inflammatory conditions, myeloid-derived suppressor cells (MDSCs) are constantly confronted with intracellular and extracellular reactive oxygen species molecules and oxidative stress. Generating mice with a constitutive activation of Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) we show a pivotal role of the antioxidant stress defense for development of these immune-modulatory cells. These mice are characterized by a massive increase of splenic CD11b + Gr-1 + cells, which exhibit typical suppressive characteristics of MDSCs. Whole transcriptome analysis revealed Nrf2-dependent activation of cell cycle and metabolic pathways, which resemble pathways in CD11b + Gr-1 + MDSCs expanded by in vivo LPS exposure. Constitutive Nrf2 activation thereby regulates activation and balance between glycolysis and mitochondrial metabolism and hence expansion of highly suppressive MDSCs, which mediate protection in LPS-induced sepsis. Our study establishes Nrf2 as key regulator of MDSCs and acquired tolerance against LPS-induced sepsis.
immune responses (2) . In addition to its important role in cancer, MDSCs expand during murine sepsis as well as in septic patients (3, 4) . Although sepsis patients have high levels of inflammatory mediators, components of their immune system are suppressed as well. This modified steady state of innate immunity after infection is referred to as innate memory (5, 6) . Innate memory is based on epigenetic reprogramming which is broadly defined as sustained change in transcription programs and cell physiology (5, 7) . Induction of innate memory is thus accompanied by significant changes in cellular metabolism. When inappropriately activated, innate memory programs can become maladaptive as in postsepsis immune paralysis, which is associated with severe energy metabolism defects of leukocytes (8) . Molecular mechanism that mediate innate memory at the level of cell types and the immunological metabolic and epigenetic processes behind are therefore an important area of research. By suppressing innate as well as adaptive immune responses, MDSCs have protective roles in the initial hyper-inflammatory reaction, however, are also involved in sepsisinduced innate immunoparalysis (3, 4, (9) (10) (11) . We would therefore specify MDSCs as central player in innate memory. However, there still remain open questions about, how expansion and functions of MDSCs are regulated in sepsis and how metabolic dysregulations of MDSCs affect innate immunity in sepsis.
Cellular metabolism and oxidative stress are intimately linked, immune cells are constantly confronted with intracellular and extracellular reactive oxygen species (ROS) molecules in steady state and moreover in inflammatory conditions. During sepsis, enhanced levels of ROS molecules, either produced by NADPH oxidases during oxidative bursts or by mitochondrial dysfunction, lead to oxidative stress conditions (12) . Interestingly immune cell types vary with regard to their ROS susceptibility and although ROS are toxic to most cells, MDSC survive despite their elevated content and release of ROS (13) . Moreover, high numbers of MDSCs arise in oxidative stress prone conditions such as inflammation, infection, and cancer.
This prompted us to analyze ROS-mediated signaling pathways in myeloid cells in steady state and sepsis. We hereby identified Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), the transcriptional regulator of the antioxidant stress defense, as key regulator of metabolic reprogramming of MDSCs. ).
MaTerials anD MeThODs

Mice strains
Nrf2
−/− mice have been described previously (15) and were bred in our animal facility and kept under standardized conditions, as were the OT-II mice, CD45.1 congenic mice (C57BL/6), and RAG −/− mice used.
lPs Treatment 8-to 10-week-old mice with at least 25 g were used for this study. Treatments were conducted with either vehicle + lethal dose 5 mg/kg BW LPS (sepsis group) or low dose + lethal doses 30 mg/kg BW LPS (tolerance group) in 250 µl 0.9% NaCl i.p. All animals were monitored thrice per day in 6 h intervals to document weight and body temperature. Rapamycin was first solved in ethanol and then diluted in 5.2% PEG/Tween in NaCl. Mice received either vehicle (5.2% PEG/Tween) or 2 mg/kg of body weight rapamycin by daily i.p. injections.
Transfer colitis
To induce transfer colitis, RAG2
−/− mice were adoptively transferred with either 2 × 
Gr1
+ cells. After 6 weeks, the mice were sacrificed. Spleens and mesenterial lymph nodes (mLNs) were harvested for further analysis. One part of the colon was fixed in formalin for histological scoring and the other part was fixed in RNAlater (Qiagen, Germany) for subsequent mRNA analysis.
histological scoring 4 µm paraffin sections from the fixed colon were cut serially, mounted onto glass slides, and deparaffinized. The colon sections were stained with hematoxylin and eosin by the Core Facility (IZKF) of the RWTH Aachen University. Blinded histological scoring was performed using a standard microscope, based on The Jackson Laboratory Score method as described previously (16, 17) . Each colon section was scored for the four general criteria: severity, degree of hyperplasia, degree of ulceration, if present, and percentage of area involved. A subjective range of 1-3 (1 = mild, 2 = moderate, 3 = severe) was used for the first three categories. Severity: focally small or widely separated multifocal areas of inflammation limited to the lamina propria were graded as mild lesions (1) . Multifocal or locally extensive areas of inflammation extending to the submucosa were graded as moderate lesions (2) . If the inflammation extended to all layers of the intestinal wall or the entire intestinal epithelium was destroyed, lesions were graded as severe (3) . Hyperplasia: mild hyperplasia consisted of morphologically normal lining epithelium that was at least twice as thick (length of crypts) as adjacent or control mucosa. Moderate hyperplasia was characterized by the lining epithelium being two or three times normal thickness, cells were hyperchromatic, numbers of goblet cells were decreased, and scattered individual crypts developed an arborizing pattern. Severe hyperplastic regions exhibited markedly thickened epithelium (four or more times normal thickness), marked hyperchromasia of cells, few to no goblet cells, a high mitotic index of cells within the crypts, and numerous crypts with arborizing pattern.
Ulceration was graded as: 0 = no ulcer, 1 = 1-2 ulcers (involving up to a total of 20 crypts), 2 = 1-4 ulcers (involving a total of 20-40 crypts), and 3 = any ulcers exceeding the former in size. A 10% scale was used to estimate the area involved in the inflammatory process (0 = 0%, 1 = 10-30%, 2 = 40-70%, 3 = >70%).
BrdU assay
Mice were fed orally with 0.8 mg/ml BrdU (BD) in drinking water. Drinking water was changed every 2 days. After 14 days mice were sacrificed, spleens and BMDCs were harvested, and BrdU incorporation was assessed by flow cytometry according to the manufacturer's instructions (BrdU Flow, Kit, BD). 
Mixed Bone Marrow chimeras
CD25
− cells and perform adoptive transfer colitis.
Flow cytometry
For surface staining, single cell suspensions were stained with anti-CD11b, anti-Gr-1, anti-CD4, anti-CD3, anti-CD8, anti-CD25, anti-CD19, anti-CD11c, anti-F4/80, anti-CD45.1, and anti-CD45.2 (all from eBioscience, Germany). To analyze Foxp3, pS6, p4EBP-1, Nos2, p-mTOR, and arginase expression, cells were fixed and permeabilized with a FOXP3 staining buffer set (eBioscience, Germany) following the manufacturer's instructions and stained with anti-Foxp3 antibodies (eBioscience, Germany), anti pS6, p4EBP-1 (BD Biosciences), anti-p-mTOR (ebioscience, Germany), anti-arginase and sheep-IgG (both R&D), or anti-NOS2 and mouse-IgG2a (both eBiosience) antibodies for 30 min. To analyze mitochondrial mass by flow cytometry, cells were incubated with 25 ng/ml nonyl acridine orange (Thermo Fischer Scientific) for 10 min at 37°C and maintained on ice until flow cytometric analysis. Glucose uptake was determined by means of a glucose uptake cell-based kit (Cayman Chemical). 2 × 10 6 cells/ml were incubated in glucose-free medium for 2 h. Afterwards 100 µg/ml 2-NBDG was added and incubation continued in a cell incubator at 37°C. Incubation was stopped by immediate transfer of cell culture plates to 4°C conditions. Cells were washed with a cell-based assay buffer according to the manufacturer's instructions and kept at 4°C until flow cytometric analysis. A total reactive oxygen species assay kit (eBioscience) was used to identify ROS, following the manufacturer's instructions. In detail, this involved incubation of the cells with ROS assay stain for 60 min at 37°C, washing once with PBS and analysis on the flow cytometer. To identify apoptotic cells, cells were first labeled with cell viability dye (eBioscience) and then incubated with fluorochrome conjugated Annexin-V (eBioscience) in Annexin-V binding buffer according to the manufacturer's instructions. BrdU staining was performed according to the manufacturer's protocol with BrdU Flow Kit (BD Pharmingen). 7-AAD staining was performed by adding 7-AAD (BD Pharmingen) directly to the cells before measurement.
Flow cytometry was carried out using FACSCanto II device (BD Biosciences, Germany). Data analysis was performed using FCS Express Software.
rna isolation and real-Time Pcr
Total RNA from isolated MDSCs and colon tissue was isolated using the RNeasy Mini Kit (Qiagen, Germany). cDNA was then generated from 200 ng total RNA using the RevertAid H Minus First Strand cDNA Synthesis Kit (Thermo Fisher Scientific, USA) according to the manufacturer's instructions. RT-PCR was performed using the SYBR Green PCR kit (Eurogentec, Germany) and data were acquired with the ABI prism 7300 RT-PCR system (Applied Biosystems/Life Technologies, Germany). Each measurement was set up in duplicate. After normalization to the endogenous reference control gene β-actin for mice, the relative expression was calculated. The sequences of primers used in this study are listed in Table S1 in Supplementary Material. seahorse assay 2 × 10 5 cells were seeded on gelatin-coated plates and OCR/ ECAR measured using the XF96 Extracellular Flux Analyzer (Seahorse Bioscience) following the manufacturer's instructions. OCR was measured in XF media containing 11 mmol/l glucose and 1 mmol/l sodium pyruvate under basal conditions and in response to 1 µmol/l oligomycin, 1 µmol/l carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), and 0.1 µmol/l rotenone plus 0.1 µmol/l antimycin A. Extracellular acidification rate (ECAR) was measured in assay medium (XF Media supplemented with 4.5 g/l glucose and 2 mM glutamine) under basal conditions and in response to 10 mM glucose, 1 M oligomycin, and 100 mM 2-deoxyglucose.
In Vitro MDsc generation 2 × 10 6 murine bone marrow cells per ml were cultured in RPMI with 2 g/l glucose supplemented with 10% heat-inactivated FCS (Life Technologies). In some experiments, glucose concentrations were adapted as indicated. To obtain BM-derived MDSCs, medium was supplemented with IL-6 (10 ng/ml) and GM-CSF (20 ng/ml) (both Peprotech). On day 3 of culture, the original medium was replaced with fresh medium containing cytokines and cultures were maintained at 37°C in 5% CO2-humidified atmosphere for an additional 3 days. To analyze effects of rapamycin, 1 µM rapamycin (Cayman Chemical) were added at day 0 and 3.
To analyze dimethyl fumarate (DMF) effects on human cells, 2 × 10 6 human PBMCs per ml were cultured in RPMI in the presence or absence of 2 µg/ml DMF.
suppression assays
DCs were generated by culturing BM cells in the presence of GM-CSF (50 ng/ml) and IL-4 (40 ng/ml) for 6 days. Cells were fed with OVA peptide (1 µM) for 2 h and extensively washed with PBS. CD4
+ OT-II cells were isolated by magnetic cell separation and labeled with cell proliferation dye (5 µM) (eBioscience) according to the manufacturer's instructions. DCs and CD4
+ T cells were co-cultured in a 1:10 ratio in U-bottom 96-well plates. MDSCs were isolated by magnetic cell isolation and were added to DC/T cell cultures in ratios of 1:1 or 1:0.5. After 3 days, proliferation of CD4 T cells was assessed by flow cytometry.
rna extraction and Microarray for gene expression analysis ) MDSCs were performed in independent triplicates using Gene Chip ® Mouse Gene 2.0 arrays (Affymetrix, Santa Clara, CA, USA). Total RNA extraction was carried out using the RNeasy Micro Kit (Qiagen, Germany) according to the manufacturer's protocol and then quantified (Nanodrop). RNA quality was assessed using the RNA 6000 Nano Assay with the 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA). Samples for the Gene 2.0 arrays were prepared and hybridized to the arrays according to the Affymetrix WT Plus Kit manual. Briefly, for each sample, 100 ng of total RNA was reversed transcribed into cDNA using a random hexamer oligonucleotide tagged with a T7 promoter sequence. After second strand synthesis, double strand cDNA was used as a template for amplification with T7 RNA polymerase to obtain antisense cRNA. Random hexamers and dNTPs spiked out with dUTP were then used to reverse transcribe the cRNA into single stranded sense strand cDNA. The cDNA was then fragmented with uracil DNA glycosylase and apurinic/ apyrimidic endonuclease 1. Fragment size was checked using the 2100 Bioanalyzer and ranged from 50 to 200 bp. Fragmented sense cDNA was biotin-endlabeled with TdT and probes were hybridized to the Gene 2.0 arrays at 45°C for 16 h with 60 rpm. Hybridized arrays were washed and stained on a Fluidics Station 450 (program: FS450 0002) and scanned on a GeneChip ® Scanner 3000 7 G (both Affymetrix). Raw image data were analyzed with Affymetrix ® Expression Console™ Software (Affymetrix, USA), and gene expression intensities were normalized and summarized with a robust multiarray average algorithm (18) . Transcripts that were expressed differently more than 1.5-fold with a raw p-value lower than 0.05 between the sample groups were categorized as regulated. Enrichment analysis for Wiki pathways was performed using WebGestalt (19) . For the enrichment analysis, only genes changed at least 1. 
statistical analysis
All data are presented as mean ± SEM or SD if indicated. Differences between two groups were evaluated using two-tailed, unpaired or paired (if indicated) Student's t-test. All statistical analysis and subsequent graphics generation were performed using GraphPad Prism version 7.0 (GraphPad Software, USA). A p-value <0.05 was considered to be statistically significant.
study approval
The study was approved by the regional government authorities and animal procedures were performed according to German legislation for animal protection. Permission for the projects was granted by the Regierungspräsident/LANUV NordrheinWestfalen. (Figure 2A ; Figure S2A in Supplementary Material) and Nos2 (Figures 2B,C) (Figures 3A,B) . Most interestingly, in addition to this, we noticed altered expression of genes belonging to metabolic as well as cell cycle pathways (Figures 3A,B) (Figures 4A,B) . Furthermore, in vitro generated MDSCs from VAV cre Keap fl/fl mice displayed higher Ki-67 expression as well ( Figure 4C) . In addition, BM CD11b (24) . On the other hand, rapamycin, the specific inhibitor of mTOR, decreased M-MDSC in mice with allografts or tumors (25) . A significant enrichment of genes of the PPP was observed in our microarray data, together with an enhancement of genes involved in glycolysis. RT-qPCR was used to validate upregulation of the following genes: glucose transporter 3 (Glut3, SLC2A3), the glucose receptor of white blood cells, hexokinase (Hk)1 and Hk2, enzymes responsible for committing glucose to the glycolytic pathway, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) which is known as vital regulator of glycolysis and furthermore promotes cell cycle progression, glucose-6-phosphate dehydrogenase (G6pd) the rate-limiting enzyme of the PPP, phosphogluconate dehydrogenase (Pgd), the second dehydrogenase in the PPP, transketolase (Tkt), which delivers excess sugar phosphates for glycolysis in the PPP, and pyruvate kinase isozyme M2 (Pkm2), which catalyzes the last step within glycolysis (Figures 5A,B) . In addition, glucose uptake, as measured by flow cytometry, was faster in VAV which suggests a more efficient uptake and faster utilization of glucose. Nrf2-deficient cells benefit from higher glucose levels, but failed to reach the same frequencies as Keap fl/fl cells even at high glucose concentrations ( Figure 5D) . Moreover, rapamycin, a specific mTOR inhibitor which is known to decrease glucose uptake during MDSC differentiation in vitro and thereby inhibits MDSC differentiation in vitro (25) Figure 5G ) and activation of mTOR signaling was reflected in the phosphorylation of S6 ribosomal protein (p-S6) ( Figure 5H ). In addition, mitochondrial mass was enhanced in VAV cre Keap fl/fl MDSCs ( Figure 5I ). Seahorse assays revealed higher maximal respiration rates (OCR) (Figures 5J,K) , while extracellular acidification rates (ECAR), a measurement of lactate production, were not enhanced (Figure 5L) , which in addition to the higher mitochondrial mass rates might suggests that VAV cre Keap fl/fl MDSCs use oxidative phosphorylation to generate ATP from glucose instead of glycolysis with subsequent lactate secretion. Overall, we conclude from these data that Keap1-deficient MDSCs exhibit higher uptake of abundant nutrients and a higher overall metabolic activity, which leads to an increase in metabolic pathways and pushes them into proliferative states.
resUlTs
VAV
nrf2 activation resembles lPs-induced MDsc expansion
Myeloid-derived suppressor cells strongly expand under septic conditions in mice and men (3, 4) . We also observed higher levels of Nrf2 protein expression in CD11b + Gr-1 + cells after treating mice with sublethal doses LPS ( Figure 6A) . We therefore speculated whether LPS- 
LPS-induced CD11b
+ Gr-1 + cells revealed higher Ki-67 expression ( Figure 6D ) and enhanced mRNA levels of genes, which belong to the glucose and PPP pathway ( Figure 6E ) as well as faster glucose uptake ( Figure 6F) .
+ Gr-1 + cells had increased ECAR on a basal level and after addition of glucose and furthermore after addition of Oligomycin, which blocks mitochondrial ATP production and promotes maximal rates of glycolysis ( Figure 6G) . In addition to this, OCR was enhanced as well under basal conditions but also after addition of Oligomycin and FCCP, which uncouples oxidative phosphorylation from electron transport and allows maximal respiration ( Figure 6H) . While OCR was enhanced in VAV cre Keap fl/fl MDSCs as well, an enhanced ECAR seems to be more specific for LPS-induced MDSCs and might occur independently of Nrf2 signaling. To proof if inhibition of mTOR influences LPS-mediated induction of MDSC in vivo, we treated mice with sublethal doses of LPS together with rapamycin. In vivo administration of rapamycin (2 mg/kg/bw i.p. every day) significantly reduced numbers of CD11b + Gr-1 + cells in spleens of LPS-treated mice ( Figure 6I ). In conclusion, these data show that LPS-induced MDSCs show some similarities with Nrf2-activated MDSCs and are as well characterized by an activation of metabolic pathways and higher proliferation states.
nrf2 activation contributes to Tlr4-Mediated MDscs expansion
To finally analyze the functional significance of our findings in vivo we performed an acute lethal model and a tolerance sepsis model. Mice were treated with either lethal doses (acute, lethal model) or either with sublethal (tolerizing) and subsequent lethal LPS doses (tolerance model). While treatment with low doses and subsequent lethal doses of LPS expectedly induced MDSC expression in wild-type mice and induced a protection against the lethal dose, Nrf2 −/− mice had to be taken out of the experiment and sacrificed at day 2 or 3 without acquiring an enhanced MDSC population (Figures 7A,B) . But it should be considered that the reduced numbers of MDSCs during the sepsis experiment in Nrf2 −/− mice might be related to the early death of the mice. However, mice with deletion of Nrf2 were not protected by a tolerizing dose of LPS and died after the second lethal dose of LPS, while WT mice that underwent the same procedure were protected and displayed expanded numbers of MDSCs. In addition, mice with a constitutive expression of Nrf2 in hematopoietic cells (VAV ) were resistant against lethal doses of LPS even without previous treatment with tolerizing LPS doses (Figures 7A,B) (Figure 7C) , the OCR was only slightly enhanced compared to LPS-induced OCR activation of WT CD11b
+ cells (Figures 7D,E) . This experiment shows clearly that LPS favors aerobic glycolysis and lactate production in CD11b
+ Gr-1 + cells independently from Nrf2, but that Nrf2 translocation indeed contributes to enhanced ATP generation from oxidative phosphorylation in MDSCs, which might be protective in LPS-induced septic shock.
DiscUssiOn
Nrf2 is a key transcriptional regulator, driving antioxidant gene expression and protection from oxidant injury, and is activated by ROS. Nrf2 regulated genes include a battery of antioxidant enzymes such as Nqo-1. Under quiescent conditions, Nrf2 is bound to Keap1 in the cytoplasm, resulting in proteasomal degradation. Cellular stimuli, such as oxidative stress, induce conformational changes in Keap1 resulting in the release of Nrf2 (26) . Subsequently, Nrf2 translocates to the nucleus and transactivates expression of genes containing an antioxidant response element in their promoter regions (27) . Nrf2 has been described before as a positive regulator of myeloid differentiation (28) and it skews the differentiation potential of HSCs toward the granulocyte-monocyte lineage (29) . Nevertheless, the role for Nrf2 activation in MDSCs in different relevant diseases like cancer is contra dictionary (13, 30, 31) . We therefore performed a comprehensive approach to study Nrf2/Keap1 signaling in MDSCs in steady state and sepsis and identified Nrf2 as a key metabolic regulator of these immunosuppressive cells.
In detail, we could show that Nrf2/Keap1 signaling enhances MDSCs in a cell intrinsic manner, Nrf2 activated MDSCs are suppressive in vitro and in vivo and reveal other characteristics of MDSCs such as expression of arginase and NOS2 and low expression of inflammatory cytokines. Furthermore, Nrf2 induces transcriptional reprogramming of MDSCs, which resembles the transcriptional profile of LPS-induced MDSCs and might thus critically contribute to LPS-mediated tolerance. While it was shown before that Nrf2 is protective in models of sepsis by suppressing LPS-induced inflammatory cytokine expression in macrophages (32) (33) (34) (35) , these studies did not address MDSCs and our observations in metabolic reprogramming of MDSCs might critically contribute to the protective role of Nrf2 in this context. Nrf2 is involved in metabolic reprogramming of cancer cells and in regulation of mitochondrial respiration (36) (37) (38) . Furthermore, a direct mTOR activation by Nrf2 has been shown in human cell lines (39) . These earlier data from other cell types support our study, as we also detected an higher metabolic activity, higher glucose uptake and mitochondrial masses, and high mTOR phosphorylation in Nrf2-induced MDSCs cells and could even block Nrf2-induced MDSC generation with rapamycin.
Collectively our study suggests that Nrf2 is a key modulator of MDSCs which might contribute to innate memory in sepsis. Nrf2 activation induces expansion of MDSCs; Nrf2 is also necessary to expand MDSCs in the situation of LPS tolerance. This can be explained by constitutive activation and availability of antioxidant enzymes in these cells and might be an important mechanism which enables the cells to enhance mitochondrial ATP production by counteracting subsequent high ROS levels at the same time. With this regard, it is interesting that Nrf2 activation in particular enhances PMN-MDSCs, which are known to produce excessive amount of ROS (41) and that Nrf2 activation also mainly reduces this high ROS levels in PMN-MDSCs and not in M-MDSCs. Therefore, PM-MDSCs may benefit more from Nrf2 activation and subsequent reduction of oxidative stress.
Host defense against recurrent infections is mediated by innate immune memory. The phenomena of trained immunity and endotoxin tolerance are examples of such innate-type memory, with trained immunity describing an adaption that results in the long-lasting capacity to respond more strongly and tolerance describing a hypoinflammatory state. However, it is not clear if these are two fundamentally divergent programs or just represent different facets of innate memory (5) . Whereas the priming with β-glucan from Candida albicans leads to a state of trained immunity with a potentiation of inflammatory cytokine production, TLR4 stimulation with LPS can induce a state of endotoxin tolerance and suppression of inflammatory cytokines. Recent studies showed that aerobic glycolysis is the metabolic basis for trained immunity (42) . The metabolism of tolerant myeloid cells, especially of MDSCs, is less clear and was matter of our study. It is generally accepted that, naïve or tolerant cells rely mainly on oxidative phosphorylation as energy sources while activated cells, e.g., after LPS stimulation, shift their metabolism toward aerobic glycolysis (43) . By contrast, leukocytes from patients with severe sepsis and immunoparalysis display a generalized metabolic defect at the level of both glycolysis and oxidative metabolism in cellular energy metabolism (5) , which means that a complete metabolic reprogramming occurs between acute sepsis and immunoparalysis. We could show that tolerizing mice with a low-dose LPS induced an activation of both glycolysis and OXPHOS in MDSCs. Mice with a constitutive Nrf2 activation already revealed at least higher OCR level and were even protected without any tolerizing pretreatment. Interestingly, MDSCs generated during infection show a strong anti-inflammatory phenotype, compared to splenic CD11b + Gr1 + cells under steady-state conditions (11) and we also detected reduced level of inflammatory cytokines in VAV cre Keap fl/fl mice compared to untreated MDSCs. This further suggests that MDSCs need to be primed to acquire an anti-inflammatory phenotype either by LPS and/or by Nrf2 activation.
One limitation of our study is that we so far only used LPS injections as a model for sepsis, therefore further studies will also include the cecal ligation and puncture model in order to test the effects of Nrf2 activation in different animal models of sepsis.
In conclusion, our data demonstrate for the first time that Nrf2/Keap signaling critically contributes to generation of tolerant MDSCs, which bear an intact cellular energy metabolism and are protective in sepsis (Figure 8) . Thereby, our study provides new insights into the regulation of MDSCs, a myeloid cell population that might be relevant in trained immunity of the innate immune system (11, 44) .
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